February 23, 2021
The year 2020 presented countless challenges resulting in heightened stress and emotion across the globe. 3CMA members have been, and continue to be, on the front lines dealing with the prolonged traumatic impacts from COVID-19 and much more. In this 3CMA webinar, Deborah Beidel, Ph.D., ABPP, will share data on the social and psychological effects of the global pandemic. She will also provide strategies to help you and your colleagues cope with the unique stressors presented during this time.
3CMA Webinar - Surviving the Strain of a Global Pandemic and Handling the Challenges of 2021
Tuesday, February 23, 2021
Her presentation will include suggestions on how you can support your friends, family, and coworkers, and even manage the most difficult residents in your community. Dr. Beidel, who directs UCF RESTORES at the University of Central Florida, is a leading expert on anxiety and post-traumatic stress disorder. If you want to help ensure you are emotionally grounded and ready for 2021, you won’t want to miss this webinar. In fact, it may be one you want to share with others throughout your organization.
About the Speaker:
Deborah C. Beidel, Ph.D., ABPP is Trustee Chair and Pegasus Professor of Psychology and Medical Education at the University of Central Florida. She received her Ph.D. in Clinical Psychology from the University of Pittsburgh and completed a post-doctoral fellowship in clinical research at Western Psychiatric Institute and Clinic. Dr. Beidel holds Diplomates in Clinical Psychology and Behavioral Psychology from the American Board of Professional Psychology. She is the author of over 300 scientific publications including journal articles, book chapters, and books on the treatment of anxiety disorders and post-traumatic stress disorder.
Dr. Beidel is also the Director of UCF RESTORES, a clinical research center dedicated to trauma and PTSD. She has been the recipient of over $31 million in federal research funding throughout her career. Her recent work focuses on developing effective treatments for PTSD for veterans, active-duty personnel, first responders, and survivors of mass shootings, utilizing technology to enhance effective treatments into standard clinical practice.